# Saratoga Health & Biotechnology C (SHPCX)

> Source: Nexqual · https://nexqual.com/SHPCX · data as of 2026-10-24 00:03 UTC · cite as "Nexqual, Saratoga Health & Biotechnology C (SHPCX), nexqual.com/SHPCX" · informational, not investment advice.

**Price:** USD 15.89 (-1.18% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 16.08 · day 15.89–15.89 · 52w 13.39–16.08 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +21.2% vs S&P 500 +13.4%; 5Y +35.5% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +21.2% | +35.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +21.3% | +6.3% |
| Volatility (annualized) | 15.1% | 14.8% |
| Max drawdown | -9.5% (Feb 2026→Jun 2026) | -15.8% (Apr 2022→Jun 2022) |

## Peers
SHPAX (Saratoga Advantage Tr Health & ) USD 24.37 -0.00% · SBHIX (Saratoga Advantage Trust: Healt) USD 29.7 -0.00% · RYCFX (Rydex Biotechnology Fund - C Cl) USD 53.99 -0.00% · RYOAX (Rydex Series Fds, Biotechnology) USD 73 +0.00% · LOGSX (Live Oak Health Sciences Fund) USD 27.17 -0.00%

## More
Full page: https://nexqual.com/SHPCX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt